Tylenol Lawsuit News: Plaintiffs Seek Access to Marketing Information in Federal Tylenol Liver Damage Litigation, Bernstein Liebhard LLP Reports

The Firm is evaluating Tylenol lawsuits on behalf of individuals who sustained serious and life-threatening liver injuries, allegedly due to the acetaminophen in Tylenol brand over-the-counter medications.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Free Case Review
Our Firm continues to hear from consumers who allegedly suffered acetaminophen-induced liver damage due to their use of Tylenol products. We will continue to closely monitor developments in this proceeding.

New York, New York (PRWEB) March 20, 2014

Dozens of Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) that claim the popular over-the-counter medications caused serious liver injuries continue to move forward in a multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. According to court documents, plaintiffs are seeking the discovery of marketing information that they say is relevant to their failure-to-warn claims. However, Johnson & Johnson Inc., McNeil PPC, Novartis Consumer Health Inc. and Perrigo Co. assert that some of the plaintiffs’ claims are blocked by an agreement the U.S. Food & Drug Administration (FDA) and the Federal Trade Commission (FTC) undertook to regulate advertisement of over-the-counter medicines. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“Our Firm continues to hear from consumers who allegedly suffered acetaminophen-induced liver damage due to their use of Tylenol products. We will continue to closely monitor developments in this proceeding,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Allegations
Court documents indicate that 125 Tylenol lawsuits are now pending in the Eastern District of Pennsylvania. All of the complaints have been filed on behalf of consumers who allegedly suffered liver injuries resulting in hospitalization, liver transplantation or death as a result of acetaminophen in Tylenol over-the-counter medicines, even when the products were used in accordance with label directions. Among other things, plaintiffs claim that the public was not provided with adequate warnings regarding the liver injury risk associated with the acetaminophen in Tylenol.

In 2009, the FDA reported that acetaminophen, the active ingredient in Tylenol-brand medications, was the leading cause of acute liver failure in the U.S. between 1998 and 2003.* According to a notice posted on the Federal Register, new limits governing the amount of acetaminophen in prescription drugs went into affect on January 14, 2014. However, these new guidelines do not apply to over-the-counter medications that contain acetaminophen.

In August 2013, Bloomberg.com reported that over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits of 325 mg per tablet mandated by the FDA for prescription medications.**

Victims of serious liver injuries allegedly related to the use of a Tylenol product may be entitled to compensation for the physical and financial damages they have suffered. To learn more about the potential link between Tylenol and liver damage, please visit Bernstein Liebhard LLP’s website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs, FDA, 2009
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with
respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author